MICA and plasma cell myeloma: 2.2. Tinostamustine Increases the Expression of MICA and MICB, Ligands for the Activating NK Cell Receptor NKG2D, in Myeloma Cell Lines and Malignant Plasma Cells from Myeloma Patients